Exploring the genetic architecture of circulating 25-hydroxyvitamin D.
Genet Epidemiol. 2013 Jan;37(1):92-8. doi: 10.1002/gepi.21694. Epub 2012 Nov 7.
Hiraki LT, Major JM, Chen C, Cornelis MC, Hunter DJ, Rimm EB, Simon KC, Weinstein SJ, Purdue MP, Yu K, Albanes D, Kraft P.
Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02215, USA. lindahiraki at mail.harvard.edu
The primary circulating form of vitamin D is 25-hydroxy vitamin D (25(OH)D), a modifiable trait linked with a growing number of chronic diseases. In addition to environmental determinants of 25(OH)D, including dietary sources and skin ultraviolet B (UVB) exposure, twin- and family-based studies suggest that genetics contribute substantially to vitamin D variability with heritability estimates ranging from 43% to 80%.
Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) located in four gene regions associated with 25(OH)D. These SNPs collectively explain only a fraction of the heritability in 25(OH)D estimated by twin- and family-based studies. Using 25(OH)D concentrations and GWAS data on 5,575 subjects drawn from five cohorts, we hypothesized that genome-wide data, in the form of (1) a polygenic score comprised of hundreds or thousands of SNPs that do not individually reach GWAS significance, or (2) a linear mixed model for genome-wide complex trait analysis, would explain variance in measured circulating 25(OH)D beyond that explained by known genome-wide significant 25(OH)D-associated SNPs. GWAS identified SNPs explained 5.2% of the variation in circulating 25(OH)D in these samples and there was little evidence additional markers significantly improved predictive ability. On average, a polygenic score comprised of GWAS-identified SNPs explained a larger proportion of variation in circulating 25(OH)D than scores comprised of thousands of SNPs that were on average, nonsignificant. Employing a linear mixed model for genome-wide complex trait analysis explained little additional variability (range 0-22%). The absence of a significant polygenic effect in this relatively large sample suggests an oligogenetic architecture for 25(OH)D.
© 2012 WILEY PERIODICALS, INC.
PMID: 23135809
PDF is attached at the bottom of this page
See also VitaminDWiki
- Poorly functioning Vitamin D Receptor (VDR) was 5X more likely in children with low vitamin D levels – July 2012
- Rheumatoid arthritis, genes and vitamin D – May 2013
- Common Vitamin D gene variants and resulting diseases – Jan 2013
- CYP27B1 gene decreases kidney production of active vitamin D – Feb 2013
- 291 genes improved expression by 2000 IU of vitamin D – RCT March 2013
- Vitamin D gene expression associated with diseases – March 2013
- Vitamin D level can be high, but little benefit: due to kidney, genes, low Magnesium etc. genetics can still be a problem even if blood levels are OK
- All items in category Genetics and Vitamin D
343 items Trying to understand the effect of genetics vitamin D levels in the blood – Jan 20136949 visitors, last modified 01 Jun, 2013, This page is in the following categories (# of items in each category)